Wireless infection detection and notification device aimed at improving clinical response times.
GREENVILLE, SC – OCTOBER 4, 2017
Patrona Medical, a medical device company and Kopis, a leading software development and Business Intelligence company, announced today their development partnership in support of Patrona Medical’s Foley Garde solution, aimed at improving intervention and care surrounding hospital-acquired infections.
The solution specifically aims to assist with the timely detection of catheter-associated urinary tract infections, which account for roughly 40 percent of all Hospital Acquired Infections. The Foley Garde solution creates an automated interface between monitoring systems and patient care providers, enabling improved infection detection times, reducing infection-associated costs, and assisting clinical staff in achieving better patient outcomes.
Kopis, through consultation with Patrona Medical, identified the product requirements for the Foley Garde solution and leveraged Zipit’s IoT connectivity and device management technologies to enable secure, wireless connectivity and cloud-based management of the solution over a cellular network.
“Selecting Kopis as my primary engineering services team provided me with great confidence that they could help pull together the appropriate technologies and partners to materialize my vision of a wirelessly connected product. In addition, as a CATH lab user of Zipit’s other enterprise products, I am very familiar with Zipit’s name and can confidently say their technology has contributed in large part to our success in providing timely care.” – James Conner, CEO, Patrona Medical
“With its near real-time detection capabilities, Patrona’s medical device will have the potential to greatly improve clinical response times and patient outcomes, and leveraging Zipit’s IoT and wireless background as the basis for the Foley Garde was a no-brainer. We see a promising future for James and the Patrona team, and are glad to be able to play our part in assisting them in bringing this idea to life.” – Adam Drewes, Chief Marketing Officer, Kopis
“Zipit is excited to be a part of Patrona Medical’s innovative approach to addressing hospital-acquired infections and improve their ability to get to trials faster while ensuring their wireless solution is secure. We look forward to seeing their continued success.” – Frank Greer, CEO, Zipit
The Foley Garde is being prepared for clinical trials and validation. To learn more about the solution and inquire about a possible trial, please visit: http://www.patronamedical.com
About Patrona Medical
Founded in 2016, Patrona Medical provides solutions that improve the quality of care for patients through increased detection and accelerated efficiency and response Most specifically the prevention of Cather Associated Urinary Tract Infections, (CAUTI). We have developed a patent pending technology that utilizes a color matrix process to determine a patient’s current colony count, allowing for intervention long before bacteria reach infectious levels.
The “Foley Garde” and “Foley Guard” are registered Trade Marks of Patrona Medical, Inc.
About Kopis
With locations in Greenville and Charleston, S.C., Kopis provides services for a wide variety of clients, ranging from Fortune 100 companies to successful start-ups. Kopis services include: software development, Microsoft Dynamics ERP solutions, business intelligence, mobile app development and SQL managed services.
For more information, visit: http://www.kopisusa.com/
About Zipit
Zipit Wireless (“Zipit”) provides business & technology solutions for the Internet of Things, that leverage highly scalable, industry-leading cloud infrastructures as well as the company’s proven cloud-based device management technologies, deep IoT consultation expertise and managed IoT services.
Zipit helps companies bring IoT products to market faster by offloading the complexities of securing, managing and supporting Internet-enabled solutions.
The “Z” logo and Zipit are registered trademarks of Zipit Wireless, Inc.
SOURCE PRNewswire/Kopis